BioSpace News Archive

The results were obtained in the performance study currently being conducted in Brazil at the Federal University of Minas Gerais (UFMG).

The company plans to expand its businesses with the rapid testing to its clients.

“We are thrilled to welcome Dan to NervGen,” stated Paul Brennan, President & CEO of NervGen.

Tarsier Pharma, a late clinical stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat patients with blinding ocular diseases, today announced that it successfully completed a pre-IND (Investigational New Drug) meeting with the U.S Food and Drug Administration (FDA)

Acrotech Biopharma Announces the Publication of Data From a Phase 1 Study of BELEODAQ ® (belinostat) Combined With Standard CHOP (Bel-CHOP) in Patients With Previously Untreated Peripheral T-cell Lymphoma

With subject follow up now completed the Company is shifting its focus to completing the data analyses and reporting associated with finalizing their Phase II Clinical Trial.

Optime Care, a nationally recognized pharmacy, distribution and patient management organization maximizing therapeutic opportunities for the treatment of orphan and rare disorders, is pleased to recognize Patient Experience Week, an annual event to celebrate the people who impact the patient experience every day, including nurses, physicians, support staff, executive professionals, caregivers, families and communities.

t. The exercise price of the Debenture Warrants issued as part of the Debenture Units remains at $0.55 per Common Share.

Specialty diagnostics company Precipio, Inc.(NASDAQ: PRPO), announced that currently, the contracted annualized revenues from signed customers for its HemeScreen POL (Physician Office Laboratory) testing system exceed $750,000 and for the reasons set forth below, by Q4-2021

Clinical Enterprise, Inc. d/b/a empowerDX, part of the Eurofins Clinical Diagnostics group of companies, announced that it is working with Uber to offer FDA-emergency use authorized, at-home COVID-19 testing kits to consumers via on-demand delivery.